LC

Ladrx Corp.

Biotechnology • Healthcare • Los Angeles, CA, United States • LADX (PNK)

LadRx Corporation, a biopharmaceutical company, engages in research and development of chemotherapeutic drugs for solid tumors in the United States. The company offers linker activated drug releases (LADR) technology, a platform consists of an organic backbone that is attached to a chemotoxic agent that targets and delivers the chemotoxic agent to the tumor environment and release within the tumor. Its lead candidates comprising LADRs 7, 8, 9, and 10 with novel derivatives of the auristatin and maytansinoid drug targeting tumors; and aldoxorubicin, which is in phase II clinical development for the treatment of pancreatic cancer. In addition, the company develops albumin companion diagnostic (ACDx) to identify patients with cancer that benefits from treatment with the four LADR lead candidates. The company was formerly known as CytRx Corporation and changed its name to LadRx Corporation in September 2022. The company was incorporated in 1985 and is headquartered in Los Angeles, California.

310 826 5648 11726 San Vicente Boulevard, Los Angeles, CA 90049, United States

Stock Performance (90 Days)

Data through Dec 24, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

LadRx Liquidates Assets Amid Leadership Resignations - TipRanks
TipRanks • Jul 31
Check out LadRx Corp's stock price (LADX) in real time - CNBC
CNBC • Oct 10
CytRx guns for a reset, rebranding as LadRx after a tough few years and a CEO change in January - Fierce Pharma
Fierce Pharma • Sep 26

Other Biotechnology Companies

View All →
CODEXIS, INC. logo Codexis, Inc.
1 layoff tracked
$144.5M market cap
VERTEX PHARMACEUTICALS INC / MA logo Vertex Pharmaceuticals Inc. / MA
$118.68B market cap
REGENERON PHARMACEUTICALS, INC. logo Regeneron Pharmaceuticals, Inc.
$82.72B market cap
ALNYLAM PHARMACEUTICALS, INC. logo Alnylam Pharmaceuticals, Inc.
$52.92B market cap
ARGENX SE logo Argenx SE
$52.62B market cap
INSMED Inc logo Insmed Inc.
$37.61B market cap

Frequently Asked Questions

Has LadRx Corp had layoffs?
No layoff events have been recorded for LadRx Corp in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does LadRx Corp have?
LadRx Corp has approximately 2 employees.
What industry is LadRx Corp in?
LadRx Corp operates in the Biotechnology industry, within the Healthcare sector.
Is LadRx Corp a publicly traded company?
Yes, LadRx Corp is publicly traded under the ticker symbol LADX on the PNK. The company has a market capitalization of approximately $0.00 billion.
Where is LadRx Corp headquartered?
LadRx Corp is headquartered in Los Angeles, CA, United States at 11726 San Vicente Boulevard, Los Angeles, CA 90049, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.